1900 Wealth Management LLC Cellectar Biosciences, Inc. Transaction History

1900 Wealth Management LLC

  • $1.09 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$3.5 - $6.9 $420,000 - $828,000
-120,000 Closed
0 $0
Q1 2022

Apr 27, 2022
BUY
$4.6 - $7.8 $276,000 - $468,000
60,000 Added 100.0%
120,000 $83,000
Q2 2021

Jul 20, 2021
BUY
$11.8 - $18.2 $708,000 - $1.09 Million
60,000 New
60,000 $71,000

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $9.17M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track 1900 Wealth Management LLC Portfolio

Follow 1900 Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1900 Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1900 Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email